watch
ImmunoGen, Inc.

ImmunoGen, Inc.

Sector: Biological Products Except Diagnostic Substances Region: MA, United States


: | Nasdaq: IMGN


Similar to: NPS Pharmaceuticals, Inc., Bebra Biogas Holding AG, BioTime, Inc.

ImmunoGen, Inc. is a biotechnology company, which develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology. It also have developed engineered linkers that keep the payload firmly attached to the antibody while the whole therapy is circulating through the bloodstream and then release it once the therapy has reached and entered a cancer cell. The company also uses antibody-drug conjugate targeted antibody payload technology together with strong antibody expertise to develop its own product candidates. ImmunoGen was founded in March 1981 and is headquartered in Waltham, MA.

News & Analysis

You may also be interested in: